Activase

Manufacturing · Wisconsin, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

6101 N 64th St, Milwaukee, Wisconsin, 53...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Activase

Learn more about Activase® (Alteplase) for Acute Ischemic Stroke Treatment. Indications Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symptom onset. Activase is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure. Limitation of Use: The risk of stroke may outweigh the benefit produced by thrombolytic therapy in patients whose AMI puts them at low risk for death or heart failure. Activase is indicated for the lysis of acute massive pulmonary embolism (PE), defined as: Acute pulmonary emboli obstructing blood flow to a lobe or multiple lung segments. Acute pulmonary emboli accompanied by unstable hemodynamics, e.g.,failure to maintain blood pressure without supportive measures. Important Safety InfoRead more
Activase's Social MediaPopular SearchesActivaseActiviseSIC Code 28,283NAICS Code 32,325Show more

Is Activase your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Activase

Compare insights from companies similar to Activase, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Activase

<$5M
1-10
Private
-
2012
N/A
<$5M
11-50
Private
$19.5M
2020
HS
Howard ShoafVice President, Digital Products & Strategy
<$5M
11-50
Private
-
2006
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Activase is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Activase is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Activase.

Activase Tech Stack

A closer look at the technologies used by Activase

Top Manufacturing Companies

Frequently Asked Questions Regarding Activase

What is Activase's official website?
Activase's official website is www.activase.com
What is Activase's Revenue?
Activase's revenue is <$5 Million
What is Activase's SIC code?
Activase's SIC: 28,283
What is Activase's NAICS code?
Activase's NAICS: 32,325
How many employees does Activase have?
Activase has 1-10 employees
What industry does Activase belong to?
Activase is in the industry of: Manufacturing, Pharmaceuticals
What is Activase competition?
Activase top competitors include: Enoxaparin Sodium Injection, Novoclinica, Xarelto, RxLightning
What technology does Activase use?
Some of the popular technologies that Activase uses are: Cloudflare Security, Cloudflare DNS
What does Activase do?

Learn more about Activase® (Alteplase) for Acute Ischemic Stroke Treatment. Indications Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symp... tom onset. Activase is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure. Limitation of Use: The risk of stroke may outweigh the benefit produced by thrombolytic therapy in patients whose AMI puts them at low risk for death or heart failure. Activase is indicated for the lysis of acute massive pulmonary embolism (PE), defined as: Acute pulmonary emboli obstructing blood flow to a lobe or multiple lung segments. Acute pulmonary emboli accompanied by unstable hemodynamics, e.g.,failure to maintain blood pressure without supportive measures. Important Safety Information Contraindications Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding; bleeding diathesis; and current severe uncontrolled hypertension. Do not administer Activase to treat acute myocardial infarction or pulmonary embolism in the following situations in which the risk of bleeding is greater than the potential benefit: active internal bleeding; history of recent stroke; recent (within 3months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding; bleeding diathesis; and current severe uncontrolled hypertension. Warnings and Precautions Bleeding Activase can cause significant, sometimes fatal, ...Read More

What are Activase social media links?
Activase Twitter page
Is Activase a public company?
Activase is private company therefore does not currently have an official ticker symbol
See more information about Activase

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.